Nanoparticles prepared using natural and synthetic polymers

Nanoparticulate Drug Delivery Systems

Volumn , Issue , 2007, Pages 51-60

  Chakravarthi, Sudhir S ^a   Robinson, Dennis H ^a   De, Sinjan ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Perrigo Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132504494     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (28)

1. Wissing SA, Kayser O, Muller RH. Solid-lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004; 56:1257-1272.
2. Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21:387-422.
3. Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002; 54:889-910.
4. Tonnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002; 28:621-630.
5. Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J Pharm Sci 1993; 82:912-917.
6. Gonzalez Ferreiro M, Tillman L, Hardee G, Bodmeier R. Characterization of alginate/ poly-l-lysine particles as antisense oligonucleotide carriers. Int J Pharm 2002; 239:47-59.
7. Wee S, Gombotz WR. Protein release from alginate matrices. Adv Drug Deliv Rev 1998; 31:267-285.
8. Zahoor A, Sharma S, Khuller GK. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents 2005; 26:298-303.
9. De S, Robinson D. Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres. J Control Release 2003; 89:101-112.
10. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100:5-28.
11. Prabaharan M, Mano JF. Chitosan-based particles as controlled drug delivery systems. Drug Deliv 2005; 12:41-57.
12. Coester CJ, Langer K,vanBriesen H, KreuterJ. Gelatinnanoparticlesbytwo step desolvation- a new preparation method, surface modifications and cell uptake. J Microencapsul 2000; 17:187-193.
13. Kaul G, Amiji M. Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J Drug Target 2004; 12:585-591.
14. Balthasar S, Michaelis K, Dinauer N, von Briesen H, Kreuter J, Langer K. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials 2005; 26:2723-2732.
15. Wolf BW, Garleb KA, Choe YS, Humphrey PM, Maki KC. Pullulan is a slowly digested carbohydrate in humans. J Nutr 2003; 133:1051-1055.
16. Gupta M, Gupta AK. Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier. J Control Release 2004; 99:157-166.
17. Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target 2003; 11:415-423; discussion 423 - 414.
18. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm 2004; 278:1-23.
19. Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release 2003; 93:151-160.
20. Chauvierre C, Labarre D, Couvreur P, Vauthier C. Novel polysaccharide-decorated poly(isobutyl oyanoacrylate) nanoparticles. Pharm Res 2003; 20:1786-1793.
21. Ubrich N, Schmidt C, Bodmeier R, Hoffman M, Maincent P. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Int J Pharm 2005; 288:169-175.
22. Vihola H, Laukkanen A, Hirvonen J, Tenhu H. Binding and release of drugs into and from thermosensitive poly(N-vinyl caprolactam) nanoparticles. Eur J Pharm Sci 2002; 16:69-74.
23. Liu J, Xiao Y, Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci 2004; 93:132-143.
24. Shen E, Pizsczek R, Dziadul B, Narasimhan B. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials 2001; 22:201-210.
25. Yi YM, Yang TY, Pan WM. Preparation and distribution of 5-fluorouracil (125) I sodium alginate-bovine serum albumin nanoparticles. World J Gastroenterol 1999; 5:57-60.
26. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR. Etoposide-incorporated t ripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 2004; 6:e23.
27. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002; 16:1217-1226.
28. De S, Miller DW, Robinson DH. Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells. Pharm Res 2005; 22:766-775.